-- Mary Elizabeth Dallas
SUNDAY, Sept. 8 (HealthDay News) -- People with low levels of a
certain protein are at greatest risk for sudden cardiac death that
occurs in the morning, a new study contends.
The researchers suggested that their findings could lead to new
treatments to reduce people's risk for this condition, in which the
heart suddenly stops beating due to electrical instability.
The findings were to be presented Sunday at the American
Chemical Society's annual meeting in Indianapolis.
"Sudden cardiac death due to this electrical instability causes an estimated 325,000 deaths annually in the United States alone," Dr. Mukesh Jain, of Case Western Reserve University in Cleveland, said in a chemical society news release. "That includes the three out of four heart disease deaths in people aged 35 to 44."
"In all too many cases, there is no second chance. The first event is the last event," Jain said. "Our research points the way toward possible ways of easing that toll -- new drugs that could reduce that risk, for example."
Sudden cardiac death most often strikes in the morning, between
6 a.m. and 10 a.m., followed by a smaller peak in the late
afternoon. Scientists have long believed that there's a link
between sudden cardiac death, the leading cause of heart attacks,
and people's circadian rhythm, the 24-hour body clock in the brain
that regulates sleep cycles.
The researchers said they discovered a protein, known as KLF15,
that plays a role in the regulation of the heart's electrical
activity. Levels of this protein change throughout the day like
clockwork to allow substances to enter and leave cells in the heart
in order to maintain a normal heartbeat.
Initially, the researchers discovered that patients with heart
failure have lower levels of this protein. Using lab mice, the
researchers then found that mice with low levels of KLF15 have the
same heart problems as people with sudden cardiac death.
"It turns out that people with low KLF15 levels are the ones that are most susceptible to these sudden-death episodes that occur in the early morning hours," Jain said. "We think that if we could in some way boost KLF15 levels in patients with heart problems, maybe we can reduce the occurrence of these arrhythmias and [sudden cardiac death]."
The researchers said they're examining drugs that increase
levels of KLF15 in the body. They noted, however, that this protein
also affects other body processes.
"If we can find out how these compounds are boosting KLF15 levels, then maybe we can make much more targeted and specific therapies for the heart that would prevent [sudden cardiac death], but leave the other KLF15-related processes alone," Jain said. He added that other researchers are trying to develop genetic tests to identify people with a mutation in the KLF15 gene that could put them at risk for sudden cardiac death.
The American Heart Association provides more information on
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.